Tyra Biosciences, Inc.
TYRA
$10.04
-$0.05-0.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -25.09% | -41.46% | -59.97% | -44.04% | -24.96% |
| Total Depreciation and Amortization | 45.38% | 41.54% | 28.87% | 25.71% | 20.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.78% | 17.06% | 43.36% | 40.67% | 15.93% |
| Change in Net Operating Assets | -111.46% | 364.06% | 303.61% | 99.99% | 208.77% |
| Cash from Operations | -39.16% | -31.14% | -44.23% | -21.70% | 0.29% |
| Capital Expenditure | 13.77% | -570.74% | -744.44% | -139.61% | -37.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 32.05% | -- | -- | -- | -- |
| Cash from Investing | 31.95% | -132,771.81% | -177,311.11% | -34,939.06% | -25,768.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13,078.72% | 16,526.23% | 18,040.07% | 26,087.66% | 143.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13,051.40% | 16,491.69% | 18,002.34% | 26,065.71% | 143.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.58% | -134.99% | -211.34% | 124.93% | -284.78% |